Hemodialysis

Serological Screening Most Cost-Effective Method For Detecting HCV

Published in Blood Weekly, July 26th, 2001

by Sonia Nichols, senior medical writer - Several methods are used for screening hemodialysis patients for hepatitis C virus (HCV), but a new investigation indicates serologically based methods are the most cost effective.

Currently, biochemical, viral, and serological methods are available for screening individuals for HCV. These methods, however, differ in sensitivity and costs. With the HCV infection rate among hemodialysis patients ranging between 8% and 10%, screening this population is a necessity. University of California at Los Angeles (UCLA) researchers report serological screening makes the most sense in terms of cost and sensitivity. Their report was...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-07-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry